[AACR] Abstract 3391: Dual inhibition of RAS and the IGF2/IGF1R pathways: a potential targeting strategy for RAS-mutated embryonal rhabdomyosarcoma

Closed

fatemeh_lotfi Post time 2024-4-27 15:16:21 | Show all posts |Read mode

Reward30points

journal：Cancer Research

Authors：Dorsay Sadeghian; Wan-Hsin Lin; James Smadbeck; Alan Panheiter; Michael Barrett; Alexa F. Mccune; Giannoula Karagouga; Sarah Johnson; Ryan W. Feathers; Faye R. Harris; Lindsey Kinsella; Taylor Berry; John Cheville; Panos Anastasiadis; Candace Granberg; Patricio Gargollo; Vasmatzis George

Published date：2023-4-4

DOI：10.1158/1538-7445.am2023-3391

PDF link：https://aacrjournals.org/cancerr ... of-RAS-and-the-IGF2

Article link：http://dx.doi.org/10.1158/1538-7445.am2023-3391

Article Source：American Association for Cancer Research (AACR)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

fatemeh_lotfi Lv.3

Intermediate member

post
reply
points
420

[AACR] Abstract 3391: Dual inhibition of RAS and the IGF2/IGF1R pathways: a potential targeting strategy for RAS-mutated embryonal rhabdomyosarcoma

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Abstract 3391: Dual inhibition of RAS and the IGF2/IGF1R pathways: a potential targeting strategy for RAS-mutated embryonal rhabdomyosarcoma Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AACR] Abstract 3391: Dual inhibition of RAS and the IGF2/IGF1R pathways: a potential targeting strategy for RAS-mutated embryonal rhabdomyosarcoma